TMTP1-Modified, Tumor Microenvironment Responsive Nanoparticles Co-Deliver Cisplatin and Paclitaxel Prodrugs for Effective Cervical Cancer Therapy

Overview of attention for article published in International Journal of Nanomedicine, June 2021

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 3 X users

Citations

dimensions_citation: 12 Dimensions

Readers on

mendeley: 13 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 1,735 followers.

230525 Cisplatin-paclitaxel is used as cancer therapy, but it doesn’t have specificity. Here, They try to improve targeting efficacy with conjugating TMTP-1 peptide (NVVRQ) that can specifically target metastatic tumor(#HeLa / SiHa cell lines are used). h

25 May 2023

Reply Repost Favourite

New article: TMTP1-Modified, Tumor Microenvironment Responsive Nanoparticles Co-Deliver Cisplatin and Paclitaxel Prodrugs for Effective Cervical Cancer Therapy https://t.co/vYHAudIh1A #uterinecancer #oncology https://t.co/yhG4idzrSd

Dove Medical Press

Article Metrics

TMTP1-Modified, Tumor Microenvironment Responsive Nanoparticles Co-Deliver Cisplatin and Paclitaxel Prodrugs for Effective Cervical Cancer Therapy

About this Attention Score

Mentioned by

Citations

Readers on